Schizophyllum commune (Schizophyllaceae) Split-Gill Mushroom

Quick Overview:

Schizophyllum commune is a remarkable and widely distributed edible mushroom, prized in traditional medicine across Asia and Africa for its profound health benefits. It is most notably recognized as the source of schizophyllan, a clinically studied polysaccharide used as an immunoadjuvant in cancer therapy. Beyond oncology, it exhibits potent antioxidant, antimicrobial, anti-inflammatory, and prebiotic properties, with emerging applications in functional foods, bioremediation, and sustainable biotechnology.

1. Taxonomic Insights

Species: Schizophyllum commune Fr.

Family: Schizophyllaceae

The Schizophyllaceae family comprises wood-decaying fungi within the order Agaricales, class Agaricomycetes, phylum Basidiomycota. Schizophyllum commune is the most well-known species within this family, distinguished by its unique split gills that split longitudinally upon drying and reopen when moistened. This adaptation allows it to thrive across diverse ecosystems worldwide, second only to fungi in the genus Aspergillus in terms of global distribution. It is found on every continent except Antarctica, colonizing decaying wood from broadleaved trees, particularly during rainy seasons.

Family Characteristics: Members of the Schizophyllaceae are saprotrophic fungi, playing an essential ecological role in decomposing lignin and cellulose in wood, thus recycling nutrients in forest ecosystems. They are characterized by their tough, leathery fruiting bodies and the ability to survive extreme desiccation and revive upon rehydration.

Related Medicinal Fungi from the Same or Related Families:

· Schizophyllum radiatum: A less common relative with similar wood-decaying properties, though less studied medicinally.

· Auricularia auricula-judae (Wood Ear/Jew's Ear): While from the Auriculariaceae family, it shares similar wood-decaying ecology and is prized in traditional medicine for its cardiovascular and prebiotic benefits.

· Pleurotus ostreatus (Oyster Mushroom): Another wood-decaying edible mushroom with overlapping immunomodulatory and antioxidant properties.

· Lentinus squarrosulus: Previously discussed, this wood-decaying mushroom shares ecological niches and similar traditional uses in African and Asian ethnomedicine.

---

2. Common Names

Scientific Name: Schizophyllum commune Fr. | English: Split-Gill Mushroom | Japanese: スエヒロタケ (Suehirotake) | Chinese: 裂褶菌 (Lie zhe jun) | Thai: Hed Kha | Nigerian (Yoruba): Ero | Congolese: Known and used medicinally in Haut-Katanga, Nord-Kivu, and Tshopo provinces | Indian: Regional names vary by state, though less documented in classical texts | Trade Names: Sonifilan (pharmaceutical preparation of schizophyllan) |

---

3. Medicinal Uses

Primary Actions: Immunomodulator, Antitumor, Antioxidant, Antimicrobial, Anti-inflammatory, Prebiotic, Hepatoprotective, Antiviral.

Secondary Actions: Antidiabetic, Neuroprotective, Genoprotective, Cholesterol-lowering, Wound healing, Anti-biofilm.

Medicinal Parts:

The fruiting body (basidiocarp) and mycelium are used medicinally, typically processed into extracts, powders, or concentrated polysaccharide fractions.

· Fruiting Body: The mature mushroom, rich in polysaccharides including schizophyllan, flavonoids, saponins, and ergosterol.

· Mycelium: The vegetative thread-like network, cultivated on various substrates for production of bioactive metabolites.

· Polysaccharide Extracts: Purified fractions, particularly schizophyllan, used in pharmaceutical applications.

· Culture Filtrate: The liquid medium after mycelial growth, containing extracellular polysaccharides and other bioactive compounds.

---

4. Phytochemicals Specific to the Plant and Their Action

· Schizophyllan (SPG): The signature bioactive polysaccharide, a β-D-glucan with a backbone of β-(1→3)-linked glucose residues and β-(1→6)-linked glucose side chains at approximately every third residue. It is a potent Immunomodulator and Antitumor agent, used clinically as an immunoadjuvant in cancer therapy. Molecular weights vary by strain from 290 kDa to over 1400 kDa, influencing bioactivity.

· Other Polysaccharides: Fruiting body polysaccharides (SCFP) are heteropolysaccharides composed primarily of mannose, galactose, and glucose with molecular weight around 290.92 kDa. Water-extracted polysaccharides (WSP) and alkali-extracted polysaccharides (ASP) show different physicochemical properties, with glucose and mannose as main monosaccharides in WSP, while ASP contains glucose, mannose, and galacturonic acid. Both exhibit Antioxidant and Prebiotic activities.

· Flavonoids: Present in significant amounts, contributing to Antioxidant, Anti-inflammatory, and Antimicrobial effects.

· Saponins: Contribute to Immunomodulatory, Antimicrobial, and cholesterol-lowering properties.

· Ergosterol: A sterol compound with Immunomodulatory and potential Anticancer effects, also a precursor to vitamin D2.

· Phenolic Compounds: Various phenolic acids contribute to Antioxidant and Anti-inflammatory activities.

· Extracellular Enzymes (Laccases, Cellulases, Pectinases, Proteases): These enzymes are responsible for lignocellulose degradation and have Biotechnological applications in bioremediation, biofuel production, and industrial processes.

· Terpenoids, Steroids, Tannins, Cardiac Glycosides: Detected in endophytic strains, contributing to Antimicrobial and Anticancer efficacy.

· Fatty Acids: Pinolenic acid, sebacic acid, and others contribute to antimicrobial and anti-inflammatory effects.

· 5'-Nucleotides (5'-GMP, 5'-IMP, 5'-CMP): Key molecules influencing the umami taste of the mushroom, making it valuable in food flavor enhancement.

---

5. Traditional and Ethnobotanical Uses Covering the Medicinal Uses

Immunomodulation and Cancer Support

Formulation: Polysaccharide extracts (schizophyllan) or mushroom decoction.

Preparation & Use: In Japanese medicine, schizophyllan (Sonifilan) is administered as an immunoadjuvant in cervical and head/neck cancer therapy. Traditionally, the mushroom is consumed as a decoction or soup for general immune enhancement.

Reasoning: Schizophyllan activates immune cells including macrophages, natural killer cells, and dendritic cells via specific receptors, enhancing tumor surveillance. The heteropolysaccharides from fruiting bodies upregulate aplasia Ras homologue member I (ARHI), regulating the PI3K/AKT signaling pathway to inhibit tumor growth and migration.

Sexual Impotence and Reproductive Health

Formulation: Whole mushroom preparation, typically cooked or dried and powdered.

Preparation & Use: In the Democratic Republic of Congo, particularly in Haut-Katanga, Nord-Kivu, and Tshopo provinces, S. commune is traditionally used to treat sexual impotence. The entire mushroom is prepared by cooking or grinding and administered orally.

Reasoning: While modern research has not fully elucidated this application, the immunomodulatory and adaptogenic properties of the mushroom may support overall vitality and endocrine function.

Infectious Diseases and Fever

Formulation: Mushroom decoction or aqueous extract.

Preparation & Use: In African traditional medicine, the mushroom is used to treat various infectious conditions and fever. In Asian systems, it is consumed for respiratory infections.

Reasoning: The antimicrobial activity against human pathogens including Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhimurium, Candida albicans, and Aspergillus brasiliensis has been scientifically validated with MIC values as low as 25 µg/ml. The antiviral properties further support this traditional use.

Gastrointestinal Health

Formulation: Mushroom decoction or powder incorporated into meals.

Preparation & Use: Across South Asia and Africa, the mushroom is consumed as food and medicine for digestive health.

Reasoning: The prebiotic polysaccharides promote growth of beneficial gut bacteria including Akkermansia muciniphila, Ligilactobacillus murinus, and Parabacteroides goldsteinii. They also resist hydrolysis during gastrointestinal digestion, reaching the colon intact to exert prebiotic effects.

Wound Healing and Skin Conditions

Formulation: Topical application of mushroom paste or extract.

Preparation & Use: In some traditional systems, the crushed mushroom is applied to wounds and skin infections.

Reasoning: The antimicrobial and anti-inflammatory properties, combined with the presence of enzymes that may aid in debridement, support wound healing applications.

---

6. Healing Recipes, Decoctions, and Preparations

Traditional Immune Support Decoction

Purpose: General immune enhancement and overall wellness.

Preparation & Use:

1. Take 10-15 grams of dried Schizophyllum commune, chopped into small pieces.

2. Simmer in 1 liter of water for 1-2 hours until the liquid is reduced by half.

3. Strain and drink warm throughout the day. The spent mushroom can be re-simmered once more.

Nutritive Mushroom Soup

Purpose: Daily nutrition and health maintenance.

Preparation & Use:

1. Clean fresh Schizophyllum commune mushrooms thoroughly.

2. Add to vegetable or chicken broth along with garlic, ginger, and traditional seasonings.

3. Simmer for 30-45 minutes until the mushrooms are tender.

4. Consume regularly as part of the diet.

Antimicrobial Decoction

Purpose: Supportive therapy for mild infections (under professional guidance).

Preparation & Use:

1. Prepare a strong decoction using 20 grams of dried mushroom in 500 ml water, simmered for 2 hours.

2. Strain thoroughly and cool.

3. Drink 50-100 ml twice daily for up to 7 days. Note: Should only be used as part of a comprehensive treatment plan.

Prebiotic Functional Food Powder

Purpose: Gut health support.

Preparation & Use:

1. Dry Schizophyllum commune mushrooms thoroughly and grind to fine powder.

2. Add 1 teaspoon to smoothies, soups, or sprinkle over meals daily.

3. The polysaccharides will resist digestion and reach the colon to feed beneficial bacteria.

---

7. In-Depth Phytochemical Profile and Clinical Significance of Schizophyllum commune (Split-Gill Mushroom)

Introduction

Schizophyllum commune represents one of the most intensively studied medicinal fungi of the modern era, primarily due to its signature polysaccharide schizophyllan, which has been developed into an approved pharmaceutical immunoadjuvant. Yet the therapeutic significance of this remarkable fungus extends far beyond this single compound. Distributed globally across every continent except Antarctica, S. commune has evolved an extraordinary capacity to survive extreme environmental conditions, producing a diverse array of bioactive metabolites that protect it from desiccation, microbial competition, and oxidative stress. These same compounds offer profound health benefits to humans. Recent research has illuminated its potential in glioma treatment through novel mechanisms involving ARHI upregulation and PI3K/AKT pathway modulation, its prebiotic effects on gut microbiota, and its antimicrobial activity against multidrug-resistant pathogens. The discovery of potent endophytic strains from medicinal plants like Nigella sativa has further expanded its therapeutic horizon, demonstrating anticancer binding affinities comparable to pharmaceutical agents.

1. Polysaccharides: The Signature Bioactive and Immunomodulatory Arsenal

Key Compounds: Schizophyllan (SPG), Fruiting Body Polysaccharides (SCFP), Water-Extracted Polysaccharides (WSP), Alkali-Extracted Polysaccharides (ASP), Subseafloor strain extracellular polysaccharide (EPS).

Quantitative Profile:

Schizophyllan is a β-D-glucan with a backbone of β-(1→3)-linked glucose residues and β-(1→6)-linked glucose side chains at approximately every third residue. Its molecular weight varies significantly by strain: commercially used ATCC 38548 produces EPS of 1400 kDa, while subseafloor strain 20R-7-F01 produces EPS of 608.8 kDa composed of 99.38% glucose. Fruiting body polysaccharides (SCFP) show molecular weight of 290.92 kDa with mannose, galactose, and glucose as main monosaccharides. Extraction rates for water-extracted polysaccharides are 11.97% and for alkali-extracted polysaccharides 14.36%, with total sugar contents of 57.71 g/kg and 52.34 g/kg respectively.

Actions and Clinical Relevance:

· Immunomodulation (Clinically Validated): Schizophyllan is the most clinically significant compound, used as an immunoadjuvant in cancer therapy, particularly for cervical and head/neck cancers. It activates multiple immune cell types including macrophages, natural killer cells, and dendritic cells through specific receptor interactions. The polysaccharide promotes RAW264.7 macrophage viability and phagocytosis, enhancing immune surveillance. The triple helix structure of these glucans is critical for receptor recognition and immunomodulatory activity.

· Antitumor and Anti-Glioma Activity (Recent Breakthrough): Fruiting body polysaccharides (SCFP) demonstrate remarkable anti-glioma activity, inhibiting U251 and U-87MG glioma cell lines in vitro. In U251 xenograft tumor models, oral administration of SCFP achieved 47.39% tumor inhibition with no significant toxic side effects. The mechanism involves upregulation of aplasia Ras homologue member I (ARHI), which regulates the PI3K/AKT signaling pathway, thereby inhibiting tumor migration and inducing apoptosis. This discovery opens new avenues for natural glioma therapies.

· Gut Microbiota Modulation: SCFP treatment in tumor-bearing mice significantly increased the relative abundance of beneficial bacteria including Akkermansia muciniphila, Ligilactobacillus murinus, and Parabacteroides goldsteinii, restoring gut microbiota structure to that of healthy controls. This prebiotic effect is complemented by studies on water and alkali extracted polysaccharides, which show strain-specific probiotic growth promotion. Both WSP and ASP resist hydrolysis during in vitro simulated digestion, reaching the colon intact to exert their prebiotic effects. ASP shows better hydrolysis resistance and greater potential as a prebiotic.

· Antioxidant (Potent and Multifaceted): Schizophyllum commune demonstrates strong antioxidant activity across multiple assays, protecting cells from oxidative stress and DNA damage. The polysaccharides show radical-scavenging capacity, with water-extracted polysaccharides exhibiting better thermal stability and antioxidant properties than alkali-extracted versions. This antioxidant protection is fundamental to its benefits in oxidative stress-related diseases including cancer, Alzheimer's, liver cirrhosis, and atherosclerosis.

· Genoprotective and Organoprotective Effects: The mushroom demonstrates protection against environmental toxins like Bisphenol A, shielding cellular DNA from damage and protecting vital organs from toxic insult.

2. Antimicrobial Compounds: The Infection-Fighting Arm

Key Compounds: Various bioactive metabolites including flavonoids, terpenoids, phenols, steroids, tannins, and cardiac glycosides. Specific fatty acids including pinolenic acid and sebacic acid.

Actions and Clinical Relevance:

· Broad-Spectrum Antibacterial Activity: Endophytic strains of S. commune isolated from Nigella sativa seeds demonstrate highly potent antimicrobial activity with MIC values of 25 µg/ml and IC50 values of 2.05 mM against human pathogens. Activity is confirmed against Staphylococcus aureus, Pseudomonas aeruginosa, Salmonella typhimurium, Clostridium sporogenes, and the pathogenic yeast Candida albicans. The antibacterial effects include biofilm-disrupting activities targeting multidrug-resistant pathogens, a particularly valuable property in an era of increasing antibiotic resistance.

· Antifungal Activity: Dual culture methods confirm antagonistic activity against pathogenic fungi including Aspergillus brasiliensis, validating traditional use for fungal infections.

· Antiviral Potential: The mushroom demonstrates antiviral properties, with particular relevance noted during the COVID-19 pandemic as a potential source of antiviral compounds.

· Extracellular Enzymes: The production of lignocellulolytic enzymes including cellulases, pectinases, laccases, and proteases contributes to its antimicrobial ecology and has industrial applications in dye decolorization and bioremediation.

3. Nutritional Composition and Functional Food Properties

Key Compounds: Protein (16.59% on grape residue substrate), dietary fiber (59.61%), carbohydrates (6.09%), lipids (2.95%), ash (6.36%), moisture (8.40%). Flavor compounds include 5'-nucleotides (5'-GMP, 5'-IMP, 5'-CMP), glutamic acid, adenosine monophosphate, phytosphingosine, didesmethylimipramine, oxyquinoline, and oleamide.

Actions and Clinical Relevance:

· Nutritional Support: The high protein content, including essential amino acids, makes S. commune a valuable protein source. The exceptional dietary fiber content (nearly 60%) supports digestive health, cholesterol management, and blood sugar regulation.

· Umami Flavor Enhancement: The presence of 5'-nucleotides, particularly 5'-GMP, contributes to the mushroom's umami taste, making it valuable in culinary applications and as a natural flavor enhancer in functional foods.

· Low Fat, High Fiber Profile: The combination of low fat and high fiber supports cardiovascular health and weight management.

4. Structural and Functional Diversity Across Strains

Strain Variability: Research demonstrates remarkable diversity in polysaccharide structure and bioactivity across S. commune strains from different habitats. Subseafloor strains isolated from nearly 2 km below the ocean floor produce significantly more EPS (5.9-7.7 g/L) than terrestrial strains (4.2 g/L) under both aerobic and anaerobic conditions. The subseafloor strain 20R-7-F01 produces EPS with 99.38% glucose content, while terrestrial strains may produce heteropolysaccharides containing fructose and arabinose. This diversity suggests that EPS production may help the fungus adapt to extreme environments, particularly anoxic conditions.

Industrial Relevance: The strong wood-degrading capabilities of S. commune enable efficient utilization of lignocellulosic materials such as corn fibers for schizophyllan production. Beyond medicinal use, schizophyllan has applications in enhanced oil recovery, bio-lubricants, cosmetics production, and food preservation. The fungus can directly produce bioethanol from lignocellulosic biomass, contributing to sustainable biofuel development.

5. Anticancer Mechanisms Beyond Polysaccharides

Endophytic Strain AVNK2: An endophytic strain isolated from Nigella sativa seeds demonstrates remarkable anticancer potency through multiple mechanisms. GC-MS analysis and molecular docking studies reveal binding affinity of -5.9 kcal/mol against colon cancer target protein (PDB ID 2HQ6) and -22.0 kcal/mol against tumor-homing peptide (PDB ID 7W8O). This confirms S. commune as a promising source for anticancer treatment beyond its well-known polysaccharide effects.

Optimization of Bioactivity: The bioactive metabolite production can be enhanced by optimizing physicochemical parameters: glucose as carbon source, beef extract as nitrogen source, pH 7.0, temperature 30°C, and 21 days of incubation. This allows for maximum therapeutic efficacy in cultivated material.

An Integrated View of Healing in Schizophyllum commune

· For Cancer Support and Immunotherapy: S. commune offers a sophisticated multi-level approach to oncology. First, direct immune activation: Schizophyllan and other polysaccharides activate macrophages, natural killer cells, and dendritic cells, enhancing the body's intrinsic tumor surveillance. This is clinically validated in cervical and head/neck cancer therapy. Second, specific anti-glioma activity: Fruiting body polysaccharides upregulate ARHI, regulating the PI3K/AKT pathway to inhibit tumor growth and migration with 47.39% tumor reduction in animal models. Third, gut microbiota restoration: By increasing beneficial bacteria like Akkermansia muciniphila, the mushroom supports the growing understanding of the gut-immune-tumor axis. Fourth, direct cytotoxic effects: Endophytic strains show binding affinity against cancer protein targets comparable to pharmaceutical agents. This comprehensive action makes S. commune one of the most clinically versatile medicinal mushrooms for oncology.

· For Infectious Disease and Antimicrobial Resistance: In an era of increasing antibiotic resistance, S. commune offers multiple advantages. Its broad-spectrum activity against bacteria, fungi, and viruses, combined with MIC values as low as 25 µg/ml, demonstrates potent direct antimicrobial effects. The biofilm-disrupting activity is particularly valuable against multidrug-resistant pathogens that form protective biofilms. The mushroom's ability to produce these compounds when cultivated on simple agricultural wastes makes it an economically viable source of new antimicrobial agents.

· For Gut Health and Metabolic Disorders: The prebiotic polysaccharides provide comprehensive digestive support. They resist digestion in the upper gastrointestinal tract, reaching the colon intact where they selectively promote beneficial bacteria. The restoration of Akkermansia muciniphila, a bacterium associated with lean body mass and metabolic health, suggests applications in obesity and metabolic syndrome. The high fiber content (nearly 60%) further supports blood sugar regulation and cholesterol management. The differential properties of water and alkali extracted polysaccharides allow for tailored prebiotic formulations depending on desired effects.

· For Oxidative Stress and Chronic Disease Prevention: The potent antioxidant activity protects cells from oxidative damage implicated in aging, cancer, cardiovascular disease, and neurodegeneration. The genoprotective effects against environmental toxins like Bisphenol A add an additional dimension of cellular protection. This makes S. commune valuable not only for treating established disease but for long-term prevention and healthy aging.

· As a Sustainable Functional Food and Industrial Resource: Beyond direct medicinal applications, S. commune represents a model of sustainable biotechnology. Its ability to grow on agricultural wastes and produce high-value compounds including schizophyllan, enzymes, and bioethanol addresses multiple environmental and economic challenges simultaneously. The dual extraction methods for polysaccharides allow for different applications based on physicochemical properties. This positions S. commune as a cornerstone organism for the emerging bioeconomy.

Toxicological Profile and Safety

Extensive toxicity studies confirm the safety of S. commune. Oral administration of aqueous extract at doses up to 5 g/kg body weight shows no harmful effects in animal models. The LD50 is determined to be higher than 5 g/kg. Over 14-day observation periods, no deaths occur, and no noticeable changes in appearance, behavior, or weight gain are observed compared to control groups. Local strains evaluated for acute toxicity through oral, intravenous, and intraperitoneal administration show no permanent signs of dangerous toxicity including changes in skin color, fur, eyes, mucous membranes, or activity toward food.

However, rare fungal infections in immunocompromised individuals underscore the importance of monitoring its use in this population. While S. commune is generally safe for healthy individuals, those with compromised immune systems should exercise caution and use only under professional supervision.

Conclusion: Schizophyllum commune stands as a paradigm of the medicinal fungus concept, demonstrating how a single species can offer clinically validated pharmaceutical agents, potent traditional medicine applications, and sustainable industrial resources. Its signature compound schizophyllan has earned a place in mainstream oncology, while recent discoveries regarding its anti-glioma activity through ARHI/PI3K/AKT pathways open new therapeutic frontiers. Its broad-spectrum antimicrobial activity addresses the urgent need for new agents against resistant pathogens. Its prebiotic effects support the growing understanding of gut health's central role in overall wellness. And its ability to grow on agricultural wastes while producing enzymes, bioethanol, and high-value compounds positions it as a key organism for sustainable biotechnology. Safe in therapeutic use, widely distributed, and increasingly cultivable, S. commune exemplifies the tremendous potential residing in our fungal biodiversity. As research continues to uncover new strains, compounds, and applications, this remarkable split-gill mushroom is poised to transition from wild-harvested delicacy to evidence-based pharmaceutical and nutraceutical resource.

---

Disclaimer:

Schizophyllum commune is generally recognized as safe based on extensive traditional use and toxicological studies confirming no adverse effects at doses up to 5 g/kg body weight. However, rare fungal infections in immunocompromised individuals have been reported, indicating that immune-compromised populations should use this mushroom only under professional supervision. Individuals with mushroom allergies should exercise caution. Those on immunosuppressive medications, anticoagulants, or anticancer therapies should consult healthcare providers before therapeutic use, as immunomodulatory effects may interact with drug mechanisms. Pregnant and breastfeeding women should consume as food rather than concentrated extracts. Accurate identification is essential when wild-harvesting. Quality varies by source, strain, and extraction method; standardized extracts with known polysaccharide content are recommended for therapeutic use. This information is for educational purposes only and is not a substitute for professional medical advice.

---

8. Reference Books, Books for In-depth Study:

· Medicinal Mushrooms: A Clinical Guide by Martin Powell

· Edible Medicinal and Non-Medicinal Mushrooms by T.K. Lim

· Mushrooms: Cultivation, Nutritional Value, Medicinal Effect, and Environmental Impact by Shu-Ting Chang and Philip G. Miles

· Fungal Polysaccharides: Current Research and Future Prospects (ACS Symposium Series)

· Handbook of Medicinal Mushrooms by S.P. Wasser

---

9. Further Study: Fungi That Might Interest You Due to Similar Medicinal Properties

1. Trametes versicolor (Turkey Tail)

· Species: Trametes versicolor | Family: Polyporaceae

· Similarities: Both are premier medicinal polypores with clinically studied polysaccharides (Polysaccharopeptide Krestin and Polysaccharopeptide in Turkey tail, schizophyllan in S. commune). Both are used as immunoadjuvants in cancer therapy. Turkey tail is more researched for breast and gastrointestinal cancers, while S. commune shows specific promise in glioma.

2. Grifola frondosa (Maitake)

· Species: Grifola frondosa | Family: Grifolaceae

· Similarities: Both are rich in β-glucans with immunomodulatory and antitumor properties. Maitake's D-fraction is clinically studied for immune enhancement in cancer patients. Both mushrooms demonstrate prebiotic effects and metabolic benefits.

3. Lentinus squarrosulus (Ikiroro)

· Species: Lentinus squarrosulus | Family: Polyporaceae

· Similarities: Both are wood-decaying edible mushrooms with overlapping traditional uses in African and Asian ethnomedicine. Both exhibit potent antimicrobial, antioxidant, and prebiotic properties. S. commune offers more clinically validated immunomodulatory polysaccharides, while L. squarrosulus provides superior nutritional density.

4. Hericium erinaceus (Lion's Mane)

· Species: Hericium erinaceus | Family: Hericiaceae

· Similarities: Both produce bioactive polysaccharides with immunomodulatory and neuroprotective potential. While Lion's Mane is renowned for nerve growth factor stimulation and cognitive support, S. commune excels in anticancer immunomodulation and antimicrobial activity.

---

-x-x-x-End-x-x-x-